These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 36870091)
1. Flavivirus nonstructural proteins and replication complexes as antiviral drug targets. van den Elsen K; Chew BLA; Ho JS; Luo D Curr Opin Virol; 2023 Apr; 59():101305. PubMed ID: 36870091 [TBL] [Abstract][Full Text] [Related]
2. Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy Celegato M; Sturlese M; Vasconcelos Costa V; Trevisan M; Lallo Dias AS; Souza Passos IB; Queiroz-Junior CM; Messa L; Favaro A; Moro S; Teixeira MM; Loregian A; Mercorelli B mBio; 2023 Feb; 14(1):e0309722. PubMed ID: 36622141 [TBL] [Abstract][Full Text] [Related]
3. Flavivirus NS4B protein: Structure, function, and antiviral discovery. Wang Y; Xie X; Shi PY Antiviral Res; 2022 Nov; 207():105423. PubMed ID: 36179934 [TBL] [Abstract][Full Text] [Related]
4. Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention. Zmurko J; Neyts J; Dallmeier K Rev Med Virol; 2015 Jul; 25(4):205-23. PubMed ID: 25828437 [TBL] [Abstract][Full Text] [Related]
12. Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review. Wahaab A; Mustafa BE; Hameed M; Stevenson NJ; Anwar MN; Liu K; Wei J; Qiu Y; Ma Z Viruses; 2021 Dec; 14(1):. PubMed ID: 35062249 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, Structure-Activity Relationships, and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease. Nie S; Yao Y; Wu F; Wu X; Zhao J; Hua Y; Wu J; Huo T; Lin YL; Kneubehl AR; Vogt MB; Ferreon J; Rico-Hesse R; Song Y J Med Chem; 2021 Mar; 64(5):2777-2800. PubMed ID: 33596380 [TBL] [Abstract][Full Text] [Related]
14. Therapeutics for flaviviral infections. Bifani AM; Chan KWK; Borrenberghs D; Tan MJA; Phoo WW; Watanabe S; Goethals O; Vasudevan SG; Choy MM Antiviral Res; 2023 Feb; 210():105517. PubMed ID: 36592668 [TBL] [Abstract][Full Text] [Related]
15. Targeting dengue virus NS4B protein for drug discovery. Xie X; Zou J; Wang QY; Shi PY Antiviral Res; 2015 Jun; 118():39-45. PubMed ID: 25796970 [TBL] [Abstract][Full Text] [Related]
16. Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease. Yao Y; Huo T; Lin YL; Nie S; Wu F; Hua Y; Wu J; Kneubehl AR; Vogt MB; Rico-Hesse R; Song Y J Am Chem Soc; 2019 May; 141(17):6832-6836. PubMed ID: 31017399 [TBL] [Abstract][Full Text] [Related]
17. High Throughput Screening Targeting the Dengue NS3-NS5 Interface Identifies Antivirals against Dengue, Zika and West Nile Viruses. Yang SNY; Maher B; Wang C; Wagstaff KM; Fraser JE; Jans DA Cells; 2022 Feb; 11(4):. PubMed ID: 35203378 [TBL] [Abstract][Full Text] [Related]
18. Methylene blue is a potent and broad-spectrum inhibitor against Zika virus Li Z; Lang Y; Sakamuru S; Samrat S; Trudeau N; Kuo L; Rugenstein N; Tharappel A; D'Brant L; Koetzner CA; Hu S; Zhang J; Huang R; Kramer LD; Butler D; Xia M; Li H Emerg Microbes Infect; 2020 Dec; 9(1):2404-2416. PubMed ID: 33078696 [TBL] [Abstract][Full Text] [Related]
19. Model System for the Formation of Tick-Borne Encephalitis Virus Replication Compartments without Viral RNA Replication. Yau WL; Nguyen-Dinh V; Larsson E; Lindqvist R; Överby AK; Lundmark R J Virol; 2019 Sep; 93(18):. PubMed ID: 31243132 [No Abstract] [Full Text] [Related]
20. N-Phenylpyridine-3-Carboxamide and 6-Acetyl-1H-Indazole Inhibit the RNA Replication Step of the Dengue Virus Life Cycle. Sow AA; Pahmeier F; Ayotte Y; Anton A; Mazeaud C; Charpentier T; Angelo L; Woo S; Cerikan B; Falzarano D; Abrahamyan L; Lamarre A; Labonté P; Cortese M; Bartenschlager R; LaPlante SR; Chatel-Chaix L Antimicrob Agents Chemother; 2023 Feb; 67(2):e0133122. PubMed ID: 36700643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]